The Canadian Cancer Clinical Trials Network (3CTN)

The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve recruitment and the efficiency and quality of academic cancer clinical trials in Canada.

Our Impact at a Glance

What we achieved in 2019-2020:

198

Portfolio trials supported

5686

patients recruited to portfolio trials

129%

increase in patients above the pre-3CTN baseline

How We Deliver Impact

The 3CTN framework supports member cancer centres conducting research across the Network and engages patient voices at every step.

Our Partners

Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.

Funding Partners

Collaborators